Advertisement
Screener

Sagimet Biosciences Inc. (SGMT) Operating Lease, Liability, Current

2.8 / 5 stars · 68/120 Roast Me

Sagimet Biosciences Inc. Operating Lease, Liability, Current

Sagimet Biosciences Inc. (SGMT) had Operating Lease, Liability, Current of $84.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Notes › Leases

us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-11

  • 2026-06-30: Operating Lease, Liability, Current $84.00K.
  • 2026-03-31: Operating Lease, Liability, Current $39.00K.
  • 2025-12-31: Operating Lease, Liability, Current $78.00K.
  • 2025-09-30: Operating Lease, Liability, Current $115.00K.
Period endOperating Lease, Liability, Current
2026-06-30$84.00K
10-Q · filed 2026-08-11
2026-03-31$39.00K
10-Q · filed 2026-05-12
2025-12-31$78.00K
10-Q · filed 2026-08-11
2025-09-30$115.00K
10-Q · filed 2025-11-13
2025-06-30$152.00K
10-Q · filed 2025-08-13
2025-03-31$39.00K
10-Q · filed 2025-05-08
2024-12-31$78.00K
10-K · filed 2026-03-11
2024-09-30$116.00K
10-Q · filed 2024-11-14
2024-06-30$153.00K
10-Q · filed 2024-08-14
2024-03-31$26.00K
10-Q · filed 2024-05-15
2023-12-31$65.00K
10-K · filed 2025-03-12
2023-09-30$103.00K
10-Q · filed 2023-11-13
2023-06-30$140.00K
10-Q · filed 2023-08-21
2022-12-31$133.00K
10-K · filed 2024-03-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Akebia Therapeutics, Inc. (AKBA)United States$0.255B-10.35